Image result for molmed logo


MolMed SpA is an Italian biotech cell&gene company focused on research, development, manufacturing, and clinical validation of innovative therapies in oncology and genetic rare diseases. MolMed built an original dual business model, including a proprietary pipeline in onco-hematology and third parties GMP services for worldwide leaders in the field of gene therapy and allogeneic CAR-T therapies. MolMed is developing its therapeutic platform based on CAR, both autologous and allogeneic; the most advanced product, CAR-T CD44v6 has entered Phase I/II in onco-hematologic indications.